6 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 19.4% per year over the past 5 years.
Operating margin has expanded, at -16.3% in the latest year.
Financial health
Total debt ($59M) exceeds cash ($22M); net debt is $37M.
Total debt has grown slower than revenue (2.2% vs 19.4% per year).
Operating income covered interest expense -2.2× in the latest year.
The company is unprofitable; at its current free-cash-flow burn it has roughly 1.9 years of cash runway.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$100M
-$21M
77.2%
-16.3%
-$11M
$59M
$22M
2024
$80M
-$27M
73.9%
-27.1%
-$18M
$60M
$13M
2023
$65M
-$33M
73.6%
-41.5%
-$20M
$57M
$18M
2022
$46M
-$47M
71.4%
-89.6%
-$37M
$53M
$7M
2021
$45M
-$36M
74.0%
-52.5%
-$25M
$50M
$19M
2020
$41M
-$24M
73.6%
-31.7%
-$22M
$53M
$26M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$22M
-$7M
81.8%
-25.2%
-$6M
$59M
$15M
Dec '25
$27M
-$3M
77.4%
-6.6%
$409000
$59M
$22M
Sep '25
$27M
-$3M
77.4%
-9.5%
-$2M
$59M
$21M
Jun '25
$24M
-$9M
77.1%
-29.0%
-$2M
$59M
$23M
Mar '25
$23M
-$7M
77.0%
-22.9%
-$8M
$60M
$27M
Dec '24
$21M
-$5M
75.4%
-17.0%
-$5M
$60M
$13M
Sep '24
$21M
-$5M
73.2%
-20.1%
-$2M
$59M
$15M
Jun '24
$19M
-$8M
73.4%
-32.4%
-$4M
$59M
$13M
Mar '24
$18M
-$9M
73.6%
-41.6%
-$8M
$58M
$13M
Dec '23
$18M
-$6M
75.2%
-28.0%
-$3M
$57M
$18M
Sep '23
$16M
-$7M
74.5%
-36.2%
-$2M
$56M
$10M
Jun '23
$17M
-$9M
72.5%
-47.6%
-$4M
$55M
$8M
Mar '23
$14M
-$10M
71.7%
-57.5%
-$10M
$54M
$7M
Dec '22
$13M
-$11M
68.8%
-77.1%
-$8M
$53M
$7M
Sep '22
$11M
-$12M
71.4%
-91.4%
-$7M
$52M
$6M
Jun '22
$10M
-$13M
73.2%
-107.6%
-$11M
$51M
$6M
Mar '22
$11M
-$11M
72.6%
-85.8%
-$12M
$50M
$7M
Dec '21
$11M
-$11M
73.4%
-82.0%
-$8M
$50M
$19M
Sep '21
$10M
-$8M
72.6%
-60.4%
-$5M
$50M
$27M
Jun '21
$13M
-$8M
74.1%
-36.5%
-$6M
$49M
$31M
Valuation over time
How the market has priced NPCE against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has risen from 3.4× (Mar '23) to 5.6× (Jun '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is NPCE growing its revenue and profit?
Over the past 5 years, NeuroPace Inc's revenue has grown 19.4% per year. These are computed facts, not advice.
How much debt does NPCE have?
As of FY2025, NeuroPace Inc reported $59M of total debt against $22M of cash; operating income covered interest expense -2.2×.
What is NPCE's profit margin?
In FY2025, gross margin was 77.2%, operating margin -16.3%, and net margin -21.5%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.